xanthenes has been researched along with cicaprost in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazar-Feldman, J; Rimon, G | 1 |
| Barnes, PJ; Giembycz, MA; Meja, KK | 1 |
2 other study(ies) available for xanthenes and cicaprost
| Article | Year |
|---|---|
A common low-affinity binding site for primary prostanoids on bovine aortic endothelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Binding Sites; Biphenyl Compounds; Carbazoles; Cattle; Cells, Cultured; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Endothelium, Vascular; Epoprostenol; Heptanoic Acids; Iloprost; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Sulfonamides; Thromboxane A2; Thromboxanes; Xanthenes; Xanthones | 1996 |
Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Biphenyl Compounds; Dinoprostone; Drug Interactions; Epoprostenol; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Prostaglandin Antagonists; Prostaglandin Endoperoxides, Synthetic; Prostanoic Acids; Receptors, Prostaglandin; Thromboxane A2; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 1997 |